Clozapine in the management of schizophrenia. All schizophrenic patients would benefit.
作者信息
Kerwin R, Lofts F
出版信息
BMJ. 1993 Jul 17;307(6897):199-200. doi: 10.1136/bmj.307.6897.199-b.
Abstract
摘要
相似文献
1
Clozapine in the management of schizophrenia. All schizophrenic patients would benefit.氯氮平治疗精神分裂症。所有精神分裂症患者都会从中受益。
BMJ. 1993 Jul 17;307(6897):199-200. doi: 10.1136/bmj.307.6897.199-b.
2
Addressing nonresponse in schizophrenia.解决精神分裂症中的无应答问题。
J Clin Psychiatry. 2012 Feb;73(2):e07. doi: 10.4088/JCP.11076tx2c.
3
Promising use of minocycline augmentation with clozapine in treatment-resistant schizophrenia.米诺环素联合氯氮平在难治性精神分裂症治疗中的潜在应用。
J Psychopharmacol. 2014 Jul;28(7):707-8. doi: 10.1177/0269881114527358. Epub 2014 Mar 19.
4
Clozapine: is another view valid?氯氮平：另一种观点是否正确？
Am J Psychiatry. 1995 Jun;152(6):821-5. doi: 10.1176/ajp.152.6.821.
5
[Clozapine--a new antipsychotic agent used in treatment resistance. A good effect but a great risk of adverse effects].[氯氮平——一种用于难治性治疗的新型抗精神病药物。疗效良好但不良反应风险极大]
Lakartidningen. 1989 Jul 12;86(28-29):2508-9.
6
Clozapine is gold standard, but questions remain.氯氮平是金标准，但仍存在问题。
Int J Neuropsychopharmacol. 2012 Oct;15(9):1201-4. doi: 10.1017/S1461145712000284. Epub 2012 Apr 4.
7
Clozapine in treatment-resistant schizophrenics.
Psychopharmacol Bull. 1988;24(1):62-7.
8
Plasma clozapine levels and clinical benefit.
J Clin Psychiatry. 1995 Nov;56(11):535-6.
9
Clozapine efficacy in schizophrenic nonresponders.
Psychopharmacol Bull. 1988;24(2):269-74.
10
Commentary on the clozapine conflict.
Am J Psychiatry. 1996 Nov;153(11):1507-8. doi: 10.1176/ajp.153.11.1507.
引用本文的文献
1
Cost-benefit analysis of risperidone and clozapine in the treatment of schizophrenia in Israel.以色列使用利培酮和氯氮平治疗精神分裂症的成本效益分析。
Pharmacoeconomics. 1998 Feb;13(2):231-41. doi: 10.2165/00019053-199813020-00006.
本文引用的文献
1
Clozapine: progress in treating refractory schizophrenia.氯氮平：难治性精神分裂症的治疗进展
BMJ. 1993 May 29;306(6890):1427-8. doi: 10.1136/bmj.306.6890.1427.
2
The effect of long-term treatment with clozapine in schizophrenia: a retrospective study in 96 patients treated with clozapine for up to 13 years.氯氮平长期治疗精神分裂症的效果：一项对96例接受氯氮平治疗长达13年患者的回顾性研究。
Acta Psychiatr Scand. 1988 May;77(5):524-9. doi: 10.1111/j.1600-0447.1988.tb05164.x.
3
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.氯氮平用于难治性精神分裂症。与氯丙嗪的双盲对照研究。
Arch Gen Psychiatry. 1988 Sep;45(9):789-96. doi: 10.1001/archpsyc.1988.01800330013001.
Zotero 插件